More than One Tandem Repeat Domain of the Extracellular Adherence Protein ofStaphylococcus aureusIs Required for Aggregation, Adherence, and Host Cell Invasion but Not for Leukocyte Activation
Open Access
- 1 December 2008
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (12) , 5615-5623
- https://doi.org/10.1128/iai.00480-08
Abstract
The extracellular adherence protein (Eap) is a multifunctionalStaphylococcus aureusprotein and broad-spectrum adhesin for several host matrix and plasma proteins. We investigated the interactions of full-length Eap and five recombinant tandem repeat domains with host proteins by use of surface plasmon resonance (BIAcore) and ligand overlay assays. In addition, agglutination and host cell interaction, namely, adherence, invasion, and stimulation of proliferation, were determined. With plasmon resonance, the interaction of full-length Eap isoforms (from strains Newman and Wood 46) with fibrinogen, fibronectin, vitronectin, and thrombospondin-1 was found to be specific but with different affinities for the ligands tested. In the ligand overlay assay, the interactions of five single tandem repeat domains (D1 to D5) of Eap-7 (from strain CI-7) with fibronectin, fibrinogen, vitronectin, thrombospondin-1, and collagen I differed substantially. Most prominently, D3 bound most strongly to fibronectin and fibrinogen. Full-length Eap, but none of the single tandem repeat domains, agglutinatedS. aureusand enhanced adherence to and invasion of host cells byS. aureus. Constructs D3-4 and D1-3 (incis) increased adherence and invasiveness compared to what was seen for single Eap tandem repeat domains. By contrast, single Eap tandem repeat domains and full-length Eap similarly modulated the proliferation of peripheral blood mononuclear cells (PBMCs): low concentrations stimulated, whereas high concentrations inhibited, proliferation. Taken together, the data indicate that Eap tandem repeat domains appear to have distinct characteristics for the binding of soluble ligands, despite a high degree of sequence similarity. In addition, more than one Eap tandem repeat domain is required forS. aureusagglutination, adherence, and cellular invasion but not for the stimulation of PBMC proliferation.This publication has 50 references indexed in Scilit:
- eapGene as Novel Target for Specific Identification ofStaphylococcus aureusJournal of Clinical Microbiology, 2008
- Use of Peptide-Major Histocompatibility Complex Tetramer Technology To Study Interactions betweenStaphylococcus aureusProteins and Human CellsInfection and Immunity, 2007
- The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solutionProtein Science, 2007
- Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureusBiochemical and Biophysical Research Communications, 2007
- The anchorless adhesin Eap (extracellular adherence protein) from Staphylococcus aureus selectively recognizes extracellular matrix aggregates but binds promiscuously to monomeric matrix macromoleculesMatrix Biology, 2006
- Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus The Journal of Experimental Medicine, 2006
- Dual Effects of Extracellular Adherence Protein fromStaphylococcus aureuson Peripheral Blood Mononuclear CellsThe Journal of Infectious Diseases, 2005
- Clonal Distribution and Phase-Variable Expression of a Major Histocompatibility Complex Analogue Protein in Staphylococcus aureusJournal of Bacteriology, 2005
- The Crystal Structures of EAP Domains from Staphylococcus aureus Reveal an Unexpected Homology to Bacterial SuperantigensJournal of Biological Chemistry, 2005
- Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID)Clinical and Experimental Immunology, 1995